脑部放疗,上午比下午敏感许多!
! c$ {4 _3 `5 W/ c- D$ {
* M: Y, j7 X3 a+ F; C' C* X
' l# a& ?- G) ?" fCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9." d3 |3 k/ M7 O/ c" @
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?1 r4 k. _) }2 W9 ~9 o$ W, l8 R
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
/ Y) y) j1 P5 \+ d& @SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
) k4 i3 U3 C- I/ H' i4 T0 y$ @0 }& |. k
Abstract
, f* d; C: O. W" @" ]BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.! a. y; ]5 ?( B; L" P$ q
+ X4 P& ]0 V. l9 _7 _) r
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic./ R/ [5 h+ Q3 j0 Y+ S- P/ p
4 K6 G: m/ k+ H4 O, _; n, T
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).3 _$ w) w) Z' G" G
7 o+ W" B8 B7 Z& g. g0 p& Y2 L
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
& _$ K4 B& e# b$ P3 B7 A7 \$ S
6 D$ y; p) N* a# g- e9 k7 [9 W |